deltatrials
Completed PHASE4 NCT00168090

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease.

Sponsor: CSL Behring

Conditions Blood Coagulation Disorders Blood Platelet Disorders Hematologic Disease Von Willebrand Disease
Interventions Blood coagulation Factor VIII and vWF, human
Updated 5 times since 2017 Last updated: Feb 10, 2011 Started: Oct 31, 2001 Completion: May 31, 2006

This PHASE4 trial investigates Blood Coagulation Disorders and Blood Platelet Disorders and is currently completed. CSL Behring leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Oct 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CSL Behring
Data source: CSL Behring

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Milwaukee, United States